Sector
PharmaceuticalsOpen
₹0.95Prev. Close
₹0.91Turnover(Lac.)
₹0.1Day's High
₹0.95Day's Low
₹0.8752 Week's High
₹052 Week's Low
₹0Book Value
₹2.34Face Value
₹2Mkt Cap (₹ Cr.)
4.83P/E
8.7EPS
0.1Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Equity Capital | 11.11 | 11.11 | 11.22 | 5.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1.25 | 1.52 | 1.85 | 3.41 |
Net Worth | 12.36 | 12.63 | 13.07 | 9.08 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Revenue | 1.58 | 7.54 | 9.51 | 12.09 |
yoy growth (%) | -78.94 | -20.63 | -21.36 | |
Raw materials | -2.05 | -6.61 | -9.91 | -8.34 |
As % of sales | 129.41 | 87.56 | 104.28 | 69 |
Employee costs | -0.35 | -0.76 | -0.98 | -0.86 |
Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Profit before tax | -0.26 | -0.73 | -4.45 | -0.02 |
Depreciation | -0.24 | -0.25 | -0.4 | -0.31 |
Tax paid | 0 | 0 | 0.35 | -0.08 |
Working capital | -1.92 | 2.24 | 3.27 | |
Other operating items |
Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -78.94 | -20.63 | -21.36 | |
Op profit growth | 29.59 | -65.72 | -369.56 | |
EBIT growth | -30.73 | -89.74 | -510.41 | |
Net profit growth | -63.73 | -82.17 | 3,695.41 |
Particulars (Rupees in Crores.) | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|
Gross Sales | 0.34 | 1.59 | 14.07 | 14.84 |
Excise Duty | 0 | 0 | 0 | 0.75 |
Net Sales | 0.34 | 1.59 | 14.07 | 14.07 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 0.72 | 1.33 | 0.93 | 0.93 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,776.15 | 150.91 | 4,20,027.58 | 237.82 | 0.77 | 4,409.74 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,855.95 | 78.49 | 1,30,370.29 | 430 | 0.61 | 2,063 | 507.93 |
Cipla Ltd CIPLA | 1,575 | 32.24 | 1,28,058.81 | 1,055.94 | 0.82 | 3,752.25 | 346.4 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,178.65 | 27.87 | 1,21,729.16 | 1,700.8 | 0.25 | 4,035.4 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,953.2 | 28.24 | 1,16,346.95 | 1,417.2 | 0.57 | 5,823.9 | 1,458.7 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Vinod S Gupta
Director
Niranjan Kumar Agarwal
Whole-time Director
Manish Jatia
Additional Director
V Siva Subbu
Whole-time Director
Jatia Omprakash Manish
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Zyden Gentec Ltd
Summary
Incorporated in 1994,Overseas Capital Ltd has been engaged in Financial services.The company came out with IPO in the year 1995 and issued 21 lakhs equity shares of Rs.10 each at par.
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.